BGI

B Group Inc Portfolio holdings

AUM $105M
1-Year Est. Return 16.92%
This Quarter Est. Return
1 Year Est. Return
+16.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$105M
AUM Growth
-$11.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
20
New
Increased
Reduced
Closed

Top Buys

1
+$4.46M
2
+$1.39M
3
+$752K
4
SYRE icon
Spyre Therapeutics
SYRE
+$335K
5
GAME icon
GameSquare
GAME
+$170K

Top Sells

1
+$22.3M
2
+$349K
3
+$186K

Sector Composition

1 Healthcare 95.58%
2 Communication Services 0.16%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
1
ADMA Biologics
ADMA
$4.58B
$35.4M 26.02%
2,412,542
+95,000
ZLAB icon
2
Zai Lab
ZLAB
$2.16B
$13.6M 9.97%
400,000
AKRO icon
3
Akero Therapeutics
AKRO
$4.49B
$11M 8.12%
232,446
CLLS
4
Cellectis
CLLS
$471M
$9.35M 6.88%
3,281,501
+25,000
TSHA icon
5
Taysha Gene Therapies
TSHA
$1.1B
$5.89M 4.33%
1,800,556
ASMB icon
6
Assembly Biosciences
ASMB
$532M
$4.5M 3.31%
175,706
-13,644
NRXPW icon
7
NRX Pharmaceuticals Warrant
NRXPW
$1.11M
$4.46M 3.28%
+3,000,000
RARE icon
8
Ultragenyx Pharmaceutical
RARE
$3.23B
$4.06M 2.99%
135,000
+25,000
AURA icon
9
Aura Biosciences
AURA
$382M
$3.54M 2.6%
572,576
IOVA icon
10
Iovance Biotherapeutics
IOVA
$853M
$3.25M 2.39%
1,500,000
SGHT icon
11
Sight Sciences
SGHT
$440M
$3.2M 2.35%
930,000
SYRE icon
12
Spyre Therapeutics
SYRE
$2.2B
$1.68M 1.23%
100,000
+20,000
PRAX icon
13
Praxis Precision Medicines
PRAX
$4.48B
$1.67M 1.23%
31,500
-3,500
ORKA
14
Oruka Therapeutics
ORKA
$1.35B
$1.44M 1.06%
75,000
APGE icon
15
Apogee Therapeutics
APGE
$4.72B
$1.39M 1.02%
35,000
GAME icon
16
GameSquare
GAME
$47.2M
$170K 0.12%
+250,000
INSM icon
17
Insmed
INSM
$44B
$22.8K 0.02%
158
-154,842
LLY icon
18
Eli Lilly
LLY
$933B
– –
0
NVDA icon
19
NVIDIA
NVDA
$4.41T
– –
0
REPL icon
20
Replimune Group
REPL
$784M
– –
0